[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Pivato et al., 2012 - Google Patents

Covalent α-synuclein dimers: chemico-physical and aggregation properties

Pivato et al., 2012

View HTML
Document ID
5962645812637591310
Author
Pivato M
De Franceschi G
Tosatto L
Frare E
Kumar D
Aioanei D
Brucale M
Tessari I
Bisaglia M
Samori B
de Laureto P
Bubacco L
Publication year
Publication venue
PloS one

External Links

Snippet

The aggregation of α-synuclein into amyloid fibrils constitutes a key step in the onset of Parkinson's disease. Amyloid fibrils of α-synuclein are the major component of Lewy bodies, histological hallmarks of the disease. Little is known about the mechanism of aggregation of …
Continue reading at journals.plos.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Similar Documents

Publication Publication Date Title
Pivato et al. Covalent α-synuclein dimers: chemico-physical and aggregation properties
Brister et al. OGlcNAcylation and phosphorylation have opposing structural effects in tau: phosphothreonine induces particular conformational order
Gade Malmos et al. ThT 101: a primer on the use of thioflavin T to investigate amyloid formation
Wu et al. Characterization of conformational and dynamic properties of natively unfolded human and mouse α-synuclein ensembles by NMR: implication for aggregation
Bisaglia et al. Structure and topology of the non‐amyloid‐β component fragment of human α‐synuclein bound to micelles: Implications for the aggregation process
Chen et al. Interaction between human prion protein and amyloid-β (Aβ) oligomers: role of N-terminal residues
Crescenzi et al. Solution structure of the Alzheimer amyloid β‐peptide (1–42) in an apolar microenvironment: Similarity with a virus fusion domain
Sibille et al. Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy
Schwalbe et al. Structural impact of tau phosphorylation at threonine 231
Mukrasch et al. Structural polymorphism of 441-residue tau at single residue resolution
Neuhaus et al. A Novel Pex14 Protein-interacting Site of Human Pex5 Is Critical for Matrix Protein Import into Peroxisomes*♦
Ramelot et al. Transient structure of the amyloid precursor protein cytoplasmic tail indicates preordering of structure for binding to cytosolic factors
Balasubramaniam et al. Hydrogen-exchange mass spectrometry for the study of intrinsic disorder in proteins
Lasorsa et al. Structural basis of tau interaction with BIN1 and regulation by tau phosphorylation
Marek et al. Residue-specific, real-time characterization of lag-phase species and fibril growth during amyloid formation: a combined fluorescence and IR study of p-cyanophenylalanine analogs of islet amyloid polypeptide
Liu et al. Mechanistic studies of peptide self-assembly: transient α-helices to stable β-sheets
Chin et al. Phosphorylation increases persistence length and end-to-end distance of a segment of tau protein
Huang et al. Fibrillogenesis of Alzheimer Aβ peptides studied by fluorescence energy transfer
De Ricco et al. Remote His50 acts as a coordination switch in the high-affinity N-terminal centered copper (II) site of α-synuclein
Kumar et al. Exploring the aggregation-prone regions from structural domains of human TDP-43
Tomoo et al. Possible role of each repeat structure of the microtubule-binding domain of the tau protein in in vitro aggregation
Savastano et al. Solid-state NMR investigation of the involvement of the P2 region in tau amyloid fibrils
Pras et al. The cellular modifier MOAG‐4/SERF drives amyloid formation through charge complementation
Ran et al. Structural and dynamic characterization of a neuron-specific protein kinase C substrate, neurogranin
Gallart-Palau et al. Uncovering neurodegenerative protein modifications via proteomic profiling